JESSICA SANCHEZ: Open Payments
NPI 1437831807 · BOYD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 39 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $981 · 2025 $1,198
Food & beverage: $1,092Education: $106
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $176 |
| Lilly USA, LLC | 6 | $166 |
| Stemline Therapeutics Inc. | 2 | $135 |
| Daiichi Sankyo Inc. | 3 | $104 |
| Incyte Corporation | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 2 | $67 |
| PFIZER INC. | 2 | $53 |
| ABBVIE INC. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
Products named: ELZONRIS, RYBREVANT, Fabhalta, Enhertu, VERZENIO, DARZALEX, MONJUVI, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
